Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives
No data addressing issues concerning disparities in participant and trial characteristics and trial outcome reporting have been established in clinical trials for H1-antihistamine-refractory chronic spontaneous urticaria (CSU). To better harmonize and compare the different treatment interventions, w...
Saved in:
Main Authors: | Surapon Nochaiwong (Author), Mati Chuamanochan (Author), Chidchanok Ruengorn (Author), Kednapa Thavorn (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of metformin for melasma treatment: a systematic review and meta-analysis
by: Pajaree Mongkhon, et al.
Published: (2023) -
Exposure to COVID-19-Related Information and its Association With Mental Health Problems in Thailand: Nationwide, Cross-sectional Survey Study
by: Mongkhon, Pajaree, et al.
Published: (2021) -
Efficacy of Omalizumab Treatment with Concomitant Antihistamines as Needed for Moderate, Refractory Chronic Spontaneous Urticaria
by: Eustachio Nettis, et al.
Published: (2018) -
Real-World Clinical Experience with Oral Cyclosporine in Antihistamine Refractory Cases of Chronic Spontaneous Urticaria
by: Sumit Sehgal, et al.
Published: (2024) -
Neutrophil/Lymphocyte Ratio as a Biomarker of Response to H1-Antihistamine Therapy in Patients with Chronic Spontaneous Urticaria
by: Xiaonan Qiu, et al.
Published: (2024)